| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 17 | |
| #2 | Canada | 2 | |
| #3 | Australia | 1 | |
| #4 | Republic of Korea | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Medical technology | |
| #5 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Heterocyclic compounds | |
| #7 | Electrotherapy | |
| #8 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kufe Donald W | 22 |
| #2 | Kharbanda Surender | 8 |
| #3 | Ohno Tsuneya | 6 |
| #4 | Kaddurah-Daouk Rima | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2013101664A1 | Muc1 ligand traps for use in treating cancers | |
| US2013039974A1 | Anti-muc1 antibodies for cancer diagnostics | |
| US2011251246A1 | Small molecule inhibitors of MUC1 and methods of identifying the same | |
| US2008241125A1 | MUC1-IκB kinase complexes and their activities | |
| CA2558382A1 | Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer | |
| US2006128720A1 | Inhibition of cell death responses induced by oxidative stress |